Structure Therapeutics, Inc. (GPCR)
16.13
-0.99
(-5.78%)
USD |
NASDAQ |
Nov 20, 16:00
16.16
+0.03
(+0.19%)
After-Hours: 20:00
Structure Therapeutics Price to Book Value : 0.9421 for Nov. 20, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 20, 2026 | 0.9421 |
| November 19, 2026 | 0.9999 |
| November 18, 2026 | 1.014 |
| November 17, 2026 | 1.061 |
| November 16, 2026 | 1.085 |
| November 13, 2026 | 1.168 |
| November 12, 2026 | 1.159 |
| November 11, 2026 | 1.224 |
| November 10, 2026 | 1.269 |
| November 09, 2026 | 1.250 |
| November 06, 2026 | 1.189 |
| November 05, 2026 | 1.114 |
| November 04, 2026 | 1.189 |
| November 03, 2026 | 1.189 |
| November 02, 2026 | 1.196 |
| October 30, 2026 | 1.277 |
| October 29, 2026 | 1.281 |
| October 28, 2026 | 1.255 |
| October 27, 2026 | 1.259 |
| October 26, 2026 | 1.232 |
| October 23, 2026 | 1.238 |
| October 22, 2026 | 1.281 |
| October 21, 2026 | 1.286 |
| October 20, 2026 | 1.336 |
| October 19, 2026 | 1.286 |
| Date | Value |
|---|---|
| October 16, 2026 | 1.231 |
| October 15, 2026 | 1.296 |
| October 14, 2026 | 1.278 |
| October 13, 2026 | 1.303 |
| October 12, 2026 | 1.396 |
| October 09, 2026 | 1.492 |
| October 08, 2026 | 1.499 |
| October 07, 2026 | 1.558 |
| October 06, 2026 | 1.604 |
| October 05, 2026 | 1.611 |
| October 02, 2026 | 1.616 |
| October 01, 2026 | 1.693 |
| September 30, 2026 | 1.826 |
| September 29, 2026 | 1.719 |
| September 28, 2026 | 1.844 |
| September 25, 2026 | 1.889 |
| September 24, 2026 | 1.894 |
| September 23, 2026 | 1.890 |
| September 22, 2026 | 1.941 |
| September 21, 2026 | 1.936 |
| September 18, 2026 | 1.840 |
| September 17, 2026 | 1.846 |
| September 16, 2026 | 1.867 |
| September 15, 2026 | 2.048 |
| September 14, 2026 | 2.021 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Eli Lilly & Co. | 31.48 |
| Novo Nordisk A/S | 5.052 |
| Merck & Co., Inc. | 7.348 |
| Prestige Consumer Healthcare, Inc. | 1.210 |
| Pfizer Inc. | 1.755 |
Price to Book Value Related Metrics
| PEG Ratio | -0.5063 |
| Price | 16.13 |
| Earnings Yield | -24.47% |
| Market Cap | 1.151B |
| PEGY Ratio | -0.5063 |